Patent · US Active

IL10 agonists and methods of use thereof

US11673930B2 · kind B2 · utility

0Cited by
11References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 11, 2021
Grant dateJun 13, 2023
Priority date—
Expiry dateAug 4, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to IL10 agonists with improved anti-tumor therapeutic efficacy. IL10 agonists disclosed herein comprise an IgG Fc domain, a linker moiety, and an IL10 moiety.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.